Endothelin-1 and neuropeptide Y plasma concentrations in renal venous blood of hypertensive patients with unilateral renal artery stenosis. 1995

A Januszewicz, and B Symonides, and M Lapiński, and J Lewandowski, and M Januszewicz, and O Rowiński, and J Szmidt, and H Ignatowska-Switalska, and B Wocial
Department of Hypertension and Angiology, Academy of Medicine, Warsaw, Poland.

The aim of the study was to investigate endothelin-1 (ET-1) and neuropeptide Y (NPY) plasma concentrations in renal venous blood of hypertensive patients with unilateral renal artery stenosis (URAS). The study was performed in 22 patients with URAS and 18 patients diagnosed as essentially hypertensive. In each subject renal arteriography and renal vein catheterisation was performed. Blood samples for ET-1, NPY and plasma renin activity (PRA) were withdrawn from renal veins and vena cava inferior, and for ET-1 and NPY from the aorta. Patients with URAS were divided in two subgroups according to the renal vein renin ratio. Both in nine patients with URAS and ratio > 1.5 and in 13 patients with URAS and ratio < 1.5, ET-1 and NPY plasma concentrations evaluated in renal venous blood of the ischaemic kidney were not different from those assessed in the contralateral side, in vena cava inferior and in the aorta. In essential hypertension, the mean ET-1 and NPY plasma concentrations of both renal veins were not different from the ET-1 and NPY plasma values assessed in renal vein of stenosed and contralateral side, vena cava and aorta of patients with URAS with and without activation of the renin system. Our study indicates that chronic ischaemia does not affect ET-1 and NPY plasma concentrations in renal venous blood of hypertensive URAS patients both with and without activation of the renin system.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009478 Neuropeptide Y A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones. Neuropeptide Y-Like Immunoreactive Peptide,Neuropeptide Tyrosine,Neuropeptide Y Like Immunoreactive Peptide,Tyrosine, Neuropeptide
D012078 Renal Artery Obstruction Narrowing or occlusion of the RENAL ARTERY or arteries. It is due usually to ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; THROMBOSIS; EMBOLISM, or external pressure. The reduced renal perfusion can lead to renovascular hypertension (HYPERTENSION, RENOVASCULAR). Renal Artery Stenosis,Obstruction, Renal Artery,Obstructions, Renal Artery,Renal Artery Obstructions,Renal Artery Stenoses,Stenoses, Renal Artery,Stenosis, Renal Artery
D012082 Renal Veins Short thick veins which return blood from the kidneys to the vena cava. Renal Vein,Vein, Renal,Veins, Renal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016232 Endothelins 21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides. Endothelium-Derived Vasoconstrictor Factors,Endothelin,Vasoconstrictor Factors, Endothelium-Derived

Related Publications

A Januszewicz, and B Symonides, and M Lapiński, and J Lewandowski, and M Januszewicz, and O Rowiński, and J Szmidt, and H Ignatowska-Switalska, and B Wocial
November 1994, Blood pressure,
A Januszewicz, and B Symonides, and M Lapiński, and J Lewandowski, and M Januszewicz, and O Rowiński, and J Szmidt, and H Ignatowska-Switalska, and B Wocial
January 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
A Januszewicz, and B Symonides, and M Lapiński, and J Lewandowski, and M Januszewicz, and O Rowiński, and J Szmidt, and H Ignatowska-Switalska, and B Wocial
January 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
A Januszewicz, and B Symonides, and M Lapiński, and J Lewandowski, and M Januszewicz, and O Rowiński, and J Szmidt, and H Ignatowska-Switalska, and B Wocial
January 1994, Nephron,
A Januszewicz, and B Symonides, and M Lapiński, and J Lewandowski, and M Januszewicz, and O Rowiński, and J Szmidt, and H Ignatowska-Switalska, and B Wocial
April 2015, Journal of hypertension,
A Januszewicz, and B Symonides, and M Lapiński, and J Lewandowski, and M Januszewicz, and O Rowiński, and J Szmidt, and H Ignatowska-Switalska, and B Wocial
January 1977, Acta medica Scandinavica,
A Januszewicz, and B Symonides, and M Lapiński, and J Lewandowski, and M Januszewicz, and O Rowiński, and J Szmidt, and H Ignatowska-Switalska, and B Wocial
April 1989, The Journal of clinical endocrinology and metabolism,
A Januszewicz, and B Symonides, and M Lapiński, and J Lewandowski, and M Januszewicz, and O Rowiński, and J Szmidt, and H Ignatowska-Switalska, and B Wocial
June 1996, Journal of hypertension,
A Januszewicz, and B Symonides, and M Lapiński, and J Lewandowski, and M Januszewicz, and O Rowiński, and J Szmidt, and H Ignatowska-Switalska, and B Wocial
November 1998, Clinical and experimental hypertension (New York, N.Y. : 1993),
A Januszewicz, and B Symonides, and M Lapiński, and J Lewandowski, and M Januszewicz, and O Rowiński, and J Szmidt, and H Ignatowska-Switalska, and B Wocial
October 2002, Nephron,
Copied contents to your clipboard!